Formulation of high dose large molecules like proteins and biologics for injectables has created a great opportunity for ...

To optimize the final formulation for a drug, it must meet many criteria beyond producing a safe and effective product. For example, it must be stable and amenable to various manufacturing steps, such ...

Nearly half of all drug shortages in 2022 were caused by quality issues or manufacturing delays, according to the Center for Drug Evaluation and Research (CDER). Evaluating the critical quality ...

A problem for biopharmaceutical companies comes as degraded proteins lead to ineffective and possibly dangerous medicines for their clients. Drug companies work on formulation development to protect ...

As the biologic pipeline diversifies across ADCs, bispecific antibodies, and fusion proteins, formulation science has become the critical discipline bridging molecular complexity and patient-ready ...

With the growing concern about the emergence of pandemics, such as the coronavirus disease 2019 (COVID-19) pandemic, drug development and repurposing are paramount. A recent study available on the ...

insights from industryYoann LefeuvreDirector of Product ManagementMicrotrac In this interview, AZoNano speaks with Yoann Lefeuvre, Director of Product Management at Microtrac. Yoann discusses ...

Monoclonal antibodies have become one of the most established and clinically successful therapeutic modalities, supported by decades of advances in discovery, engineering, and manufacturing. Many ...

Medications such as Ozempic and Mounjaro are composed of molecules called acylated peptides that are designed to circulate in the body and regulate insulin production. This enables adults with type 2 ...